REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Implementation of the third programme of Union action in the field of health (2018)
Date: 2020-11-06
Institutions: Directorate-General for Health and Food Safety, European Commission
Subjects: EU programme, disease prevention, health care, health care system, implementation of the budget, innovation, programme budgeting, public health

EN 

  EN 

   EUROPEAN COMMISSION  Brussels, 6.11.2020  COM(2020) 691 final  REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Implementation of the third programme of Union action in the field of health (2018)  {SWD(2020) 256 final}  
 
 
Table of Contents 

INTRODUCTION ...................................................................................................................... 3 

HIGHLIGHTS OF THE YEAR ................................................................................................. 5 

BUDGET IMPLEMENTATION ............................................................................................... 8 

1. 

2. 

3. 

Priorities ....................................................................................................................... 8 

Execution of the operational budget by financing mechanism .................................. 11 

Beneficiaries .............................................................................................................. 12 

MAIN COMMUNICATION ACTIONS ................................................................................. 12 

 
 
 
 
 
 
INTRODUCTION 

This  report  covers  the  implementation  of the  annual work  programme  for  2018  (2018  AWP)  of  the 
third health programme for 2014-20201 (‘the programme’). Article 13(1) of the Programme Regulation 

states  that  the  European  Commission  must  report  to  the  Health  Programme  Committee  on  the 

implementation of all actions funded through the programme, and must keep the European Parliament 

and the Council informed. This report, which provides information on the 2018 budget and how it was 

used, is intended to meet the second requirement. 

The Commission staff working document accompanying this report presents the key actions co-funded 

under  the  programme  whose  results  became  available  in  2018,  together  with  tables  detailing  all  co-

funded  activities  and  contracts.  It  also  includes  information  on  the  actions  implemented  under  the 

main thematic priorities of previous AWPs whose results also became available in 2018.  

The 2018 AWP was marked by the first ever call for projects to support the implementation of existing 

best practices identified and validated on the basis of agreed criteria by the Steering Group on Health 
Promotion, Disease Prevention and Management of Non-Communicable Diseases2 . 

Under Objective 1 (Promote health, prevent diseases and foster supportive environments for healthy 

lifestyles), five projects were funded with a total EU contribution of  EUR 6.8 million to support best 

practices  for  promoting  health  and  preventing  non-communicable  diseases  to  reduce  health 

inequalities and scale up integrated care.  

Under Objective 2 (Protect Union citizens from serious cross-border health threats), the focus in 2018 

was on strengthening preparedness, including laboratory capacities, and on implementing international 
health regulations3 in the EU. Joint action was launched to build capacity to counter health threats in 

EU  countries,  including  stepping  up  cooperation  with  neighbouring  countries.  The  overall  EU 

contribution was EUR 7.9 million.  

Objective  3  (Contribute  to  innovative,  efficient  and  sustainable  health  systems)  saw  the  launch  of 

several actions. Examples include the voluntary cooperation between Member States’ national pricing 

and  reimbursement  authorities  on  the  pricing  of  pharmaceutical  products  (known  as  EURIPID 

cooperation),  the  second  phase  of  the  information  and  communication  campaign  on  the  new 

1  Regulation  (EU)  No  282/2014  of  the  European  Parliament  and  of  the  Council  of  11  March  2014  on  the  establishment  of  a  third 
programme for the Union’s action in the field of health (2014-2020) and repealing Decision No 1350/2007/EC (OJ L 86, 21.3.2014, p. 
1). 
https://ec.europa.eu/health/non_communicable_diseases/steeringgroup_promotionprevention_en  
https://www.who.int/ihr/about/en/ 

3 

2 

3 

 
 
                                                      
Regulation on medical devices4, and meetings of the EU expert group working with effective ways of 

investing in health and the joint assessment of medical devices.  

Under Objective 4 (Facilitate access to better and safer healthcare for Union citizens), the programme 

funded: 

 

the Orpha Codes project, designed to expand coding for identifying rare diseases in  national 

health information and reimbursement systems; 

 

the  administration  of  the  23  existing  European  Reference  Networks  (ERNs)  and  the 

establishment of a new ERN, eUROGEN; and 

 

the continued operation up to 2021 of the Orphanet Network, bringing together national teams 

throughout the EU to collect, validate and disseminate key information on rare diseases. 

The  Commission  and  the  Consumers,  Health,  Agriculture  and  Food  Executive  Agency  (Chafea) 

ensure  that  the  programme’s  results  are  publicised  widely  through  appropriate  communication  and 

dissemination activities. Member States and non-EU countries participating in the programme are also 

encouraged to engage in disseminating the results of the co-funded actions and to seek synergies with 

other  EU funding  programmes.  These  promotional activities  included  holding  8 information  days  to 

promote the funding opportunities offered under the 2018 AWP, in cooperation with the network of 
national focal points (NFPs)5. 

In parallel with these initiatives, the Commission is responsible for monitoring the implementation of 

the  third  health  programme.  Chafea  and  DG  SANTE  have  contributed  to  the  data  gathering  study, 

which  involved  examining  documents  on  70  actions  (technical  reports,  sustainability  plans, 

evaluations,  etc.),  to  review  and  extract  relevant  data  for  the  baseline  analysis  and  modelling  of 

impacts. This study informed the Commission’s decision on future EU action on health in the multi-
annual financial framework (MFF) for 2021-20276. 

4  Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices, amending Directive 
2001/83/EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and repealing Council Directives 90/385/EEC and 
93/42/EEC (OJ L 117, 5.5.2017, p. 1). 

5  The NFPs are designated by the Member States and other countries participating in the programme. Their function is to help the 

Commission promote the programme and disseminate its results and the information available on its impact. 

6  COM(2020) 405 final. 

4 

 
 
 
 
                                                      
HIGHLIGHTS OF THE YEAR 

The 2018 AWP broadly addressed the four specific objectives of the health programme.  

Under Objective 1 (Promote health, prevent diseases and foster supportive environments for healthy 

lifestyles),  Chafea  launched  three  calls  for  projects  on  the  implementation  of  best  practices  on 

promotion of good health, prevention of non-communicable diseases and scaling up integrated care.  

The first call dealt with the implementation of existing best practices identified by the Member States 

and  validated  according  to  agreed  criteria  by  the  Steering  Group  on  Health  Promotion,  Disease 

Prevention and Management of Non-Communicable Diseases.   

Two project grants were co-funded to support the transfer of best practices and help scale them up at 

national and European level. These practices fell into the areas of health promotion, prevention of non-

communicable diseases and reduction of health inequalities. 

1.  The  purpose  of  the  #Stay  Healthy  -  Cardiovascular  Risk  Prevention  (YOUNG50)  project  is  to 

transfer the Italian CARDIO 50 screening model programme for active prevention in 50 year-olds, 

which constitutes best practice, to Lithuania, Romania and Luxembourg. Through early detection, 

treatment of risk factors and follow-up, it is expected to benefit those who receive counselling and 

to  improve  their  lifestyles  or  medical  parameters.  EUR 983  255  in  EU  funding  was  made 

available. 

2.  The European Physical Activity on Prescription model (EUPAP) project is designed to transfer the 

Swedish  model  for  physical  activity  on  prescription,  classed  as  best  practice,  to  10  other  EU 

countries. EU funding amounted to EUR 1 346 154. 

The  second  call  focused  on  integrated  care,  the  proposed  actions  being  designed  to  help  healthcare 

authorities  reform  their  healthcare  systems.  The  set  objective  was  to  help  local  and  regional  health 

authorities  develop  the  capacity  needed  to  implement  integrated  care  by  following  the  main  design 

principles  and  related  building  blocks  identified  in  this  area  by  the  expert  group  on  health  systems 
performance assessment7. The following two projects were funded:  

1.  Evidence-based guidance to scale up integrated care in Europe (VIGOUR)8. The project, based on 

a  consortium  of  15  beneficiaries  from  9  EU  countries  and  the  UK,  received  EU  funding  of 

EUR 1 827 608. 

7  https://ec.europa.eu/health/systems_performance_assessment/policy/expert_group_en  
8   https://webgate.ec.europa.eu/chafea_pdb/health/projects/826640/partners; and https://www.vigour-integratedcare.eu/  

5 

 
 
                                                      
2.  Personalised  knowledge  transfer  and  access  to  tailored  evidence-based  assets  on  integrated  care 
(SCIROCCO  Exchange)9.  The  project  explores  the  readiness  of  local  environments  for  the 

adoption of integrated care, using the SCIROCCO online self-assessment tool to understand local 

needs  and  the  reasons  for  transferring  the  integrated  care  mode.  This  will  serve  as  a  basis  for 

designing  a  tailored  capacity-building  approach  and  personalised  assistance  to  national  and 

regional health and social care authorities. The project, based on a consortium of 14 beneficiaries 

from 8 EU countries and the UK, received EU funding of EUR 1 508 988. 

The third call focused on nutrition, expanding the transfer of the wholegrain promotion initiatives10 to 

interested countries.  

The  purpose  of  the  European  action  on  wholegrain  partnerships  (WholEUGrain)  is  to  facilitate  the 

transfer  of  the  Danish  best  practice  model  for  a  wholegrain  partnership and  to  promote  good  health 

through healthy diets. By developing country-based wholegrain public/private partnerships, the project 

will support disease prevention, reduce inequalities and establish supportive environments for healthy 

lifestyles. The  project  brings  together  five  partners  from  four  countries  and  received  EU  funding  of 

EUR 855 410. 

Through  a  service  contract  under  the  same  objective,  Chafea  undertook  other  activities  related  to 

alcohol-related harm reduction to support implementation of best practices, including those identified 

by  EU  countries  under  the  joint  action  on  reducing  alcohol-related  harm  (2014-2016).  Chafea  also 

managed a number of studies supporting the implementation of EU legislation on tobacco products.  

Under Objective 2 (Protect Union citizens from serious cross-border health threats), the SHARP joint 
action11  got  under  way  in  EU  countries  and  other  countries  participating  in  the  programme.  The 

purpose  of  the  joint  action  is  to  improve  preparedness  in  the  EU  to  cope  with  serious  cross-border 

threats to health and support the implementation of international health regulations. A further aim is to 
step  up  the  implementation  of  EU  legislation  on  serious  cross-border  threats  to  health12.  The  joint 

action  involves  26  associated  partners,  33  affiliated  entities  and  9  collaborating  partners  in  30 

countries  (24  EU  countries,  3  EEA/EFTA  members  and  3  European  neighbourhood  countries).  It 

received an EU contribution of EUR 7.9 million.  

9  Personalised Knowledge Transfer and Access to Tailored Evidence-Based Assets on Integrated Care: SCIROCCO Exchange 
[SCIROCCO Exchange] [826676] – Project, https://webgate.ec.europa.eu/chafea_pdb/health/projects/826676/summary  and 
https://www.sciroccoexchange.com/  

10 https://ec.europa.eu/jrc/en/health-knowledge-gateway/promotion-prevention/nutrition/whole-grain 
11

  SHARP Joint Action - Strengthened International HeAlth Regulations and Preparedness in the EU, http://www.sharpja.eu  

12 

Decision No 1082/2013/EU of the European Parliament and of the Council of 22 October 2013 on serious cross-border threats to health 
and repealing Decision No 2119/98/EC (OJ L 293, 5.11.2013, p. 1). 

6 

 
 
                                                      
Under  Objective  3  (Contribute  to  innovative,  efficient  and  sustainable  health  systems),  a  series  of 

activities  was  funded  that  involved  support  to  the  implementation  of  the  regulations  on  medical 

devices and in vitro diagnostic medical devices, including the development and implementation of the 
new European Database for Medical Devices (EUDAMED 13). 

Finally,  under  Objective  4  (Facilitate  access  to  better  and  safer  healthcare  for  Union  citizens)  the 

ERNs  received  financial  support  for  their  coordination,  particularly  in  the  form  of  3-year  grants 

running until the end of the programme. The programme also supported the independent assessment of 

healthcare  providers  applying  to  join  existing  ERNs.  The  2018  AWP  also  included  direct  grant 

funding for one additional ERN (eUROGEN), as well as the Orphanet database network. 

13 https://ec.europa.eu/health/md_eudamed/overview_en 

7 

 
 
 
 
                                                      
BUDGET IMPLEMENTATION 

The  overall  budget  for  the  third  health  programme  for  2014-2020  was  EUR  449.4  million.  This 

includes  EUR 30.6  million  in  operating  costs  for  Chafea,  which  is  mandated  by  the  Commission  to 

manage  the  programme.  Chafea  has  been  providing  the  Commission  with  technical,  scientific  and 
administrative assistance in implementing the health programme since 200514. It organises annual calls 

for  proposals,  coordinates  the  evaluation  of  submissions,  negotiates,  signs  and  manages  grant 

agreements  and  disseminates  the  results  of  the  actions.  It  is  also  responsible  for  most  procurement 

procedures. 

The budget set out in the work plan for 2018 was EUR 68 325 543.65, broken down as follows: 

  operational  expenditure  EUR 60  467 000,  corresponding 

to  budget 

line  17  03  01 

(‘Encouraging  innovation  in  health,  increasing  the  sustainability  of  health  systems  and 

protecting Union citizens from serious cross-border health threats’);  

 

additional  contributions  of  EUR 1 952 043.65  from  EFTA/EEA15  and  other  non-EU 
countries16 participating in the programme; 

 

administrative expenditure EUR 1 500 000, corresponding to budget line 17 01 04 02; 

  budget for Chafea’s operating costs EUR 4 406 500, corresponding to budget line 17 01 06 02. 

The operational budget totalled EUR 62 419 043. 

EUR 61 322 254.98  (98.24%)  were  committed  under 

the  2018  AWP.  Chafea  committed 

EUR 45 976 468.52  and  DG  SANTE  EUR 15 345 786.46,  covering  part  of  procurement  and  other 

actions.  Of  the  overall  commitment,  unused  appropriations  amounted  to  EUR  1 096 788.67, 

corresponding to 1.76% of the total. 

1. 

Priorities 

In  2018,  the  total  operational  budget  implemented  (EUR 61  322  254.98)  was  assigned  to  the  four 
specific programme objectives as follows:  

14  Commission Decision 2004/858/EC of 15 December 2004 setting up an executive agency, the ‘Executive Agency for the Public Health 
Programme’, for the management of Community action in the field of public health – pursuant to Council Regulation (EC) No 58/2003 
(OJ  L  369,  16.12.2005,  p. 73)  amended  by  Commission  Decision 2008/544/EC  of  20  June  2008 amending  Decision  2004/858/EC  in 
order to transform the ‘Executive Agency for the Public Health Programme’ into the ‘Executive Agency for Health and Consumers’ (OJ 
L  173,  3.7.2008,  p.  27);  from  December  2014  the  Executive  Agency  for  Health  and  Consumers  (EAHC)  was  replaced  by  the 
Consumers,  Health,  Agriculture  and  Food  Executive  Agency  (Chafea)  by  Commission  Implementing  Decision  2014/927/EU  of  17 
December  2014  amending  Implementing  Decision  2013/770/EU  in  order  to  transform  the  ‘Consumers,  Health  and  Food  Executive 
Agency’ into the ‘Consumers, Health, Agriculture and Food Executive Agency’ (OJ L 363, 18.12.2014, p. 183). 

15  Norway and Iceland. 
16  Serbia, Bosnia and Herzegovina, and Moldova. 

8 

 
 
                                                      
1.  Health  promotion  -  EUR 15  796  420.66  (26%  of  the  operational  budget)  for  promoting 

health, preventing diseases and fostering supportive environments for healthy lifestyles, taking 

into account the ‘health in all policies’ principle; 

2.  Health  threats  –  EUR 7  900  000  (13%  of  the  operational  budget)  for  protecting  Union 

citizens from serious cross-border health threats; 

3.  Health  systems  –  EUR 8  422  838.09  (14%  of  the  operational  budget)  for  contributing  to 

innovative, efficient and sustainable health systems; 

4.  Better  and  safer  healthcare  –  EUR 25  455  254.83  (42%  of  the  operational  budget)  for 

facilitating access to better and safer healthcare for Union citizens. 

In  addition,  cross-cutting  activities  (IT  activities,  communication,  reimbursement  of  expert 

evaluators) accounted for EUR 3 747 741.40 (6% of the operational budget). 

Chart 1: Operational budget by third health programme objectives in 2018

5. Horizontal 
6% 

1. Health 
promotion  
26% 

[CATEGORY 
NAME] 
42% 

 2. Health threats 
13% 

3. Health systems 
14% 

In the 2018 budget allocation to the programme’s various thematic priorities, Chart 2 below shows that 

the  ERNs  rank  highest,  followed  by  capacity  building  to  cope  with  health  threats,  with  chronic 

diseases in third place. 

9 

 
 
 
Chart 2: Operational budget by thematic priority in 2018 

s
n
o

i
l
l
i

m
R
U
E

20
18
16
14
12
10
8
6
4
2
0

To reach its objectives, the programme was implemented through a wide range of funding instruments. 

These are: 

  project grants, including the specific mono-beneficiary grant agreement for the ERNs for rare, 

low-prevalence and complex diseases; 

  operating grants to support non-governmental organisations (NGOs); 

 

actions co-financed with Member State authorities (joint actions, JAs); 

  direct grant agreements (DGAs) with international organisations; 

  public procurement; and 

  other actions, such as support to the scientific committees, administrative agreements with the 

Joint Research Centre and EUROSTAT, and grants for Presidency conferences. 

Competitive  calls  were  used  to  select  actions  for  funding,  e.g.  for  projects  and  procurement.  JAs, 

grants to international organisations and conferences organised by European Council presidencies are 

DGAs  because  of  their  monopoly  situations  (de  facto  or  de  jure).  External  reviewers  (JAs),  DG 

SANTE and Chafea officials evaluate the proposals to ensure that these co-funded actions meet certain 

quality standards. 

The  administrative  budget  covered  expenditure  on  matters  such  as  study  meetings  of  experts, 

communication, and technical and administrative assistance for IT systems. 

10 

 
 
 
 
 
 
2. 

Execution of the operational budget by financing mechanism 

Type of financing mechanism 

Implementation (EUR) 

Share of mechanism 

in total implemented 

budget (%) 

Grants  under  call  for  proposals  or 

30 674 796.67 

invitation 

Project  grants, 

including  other  DGA 

11 095 795.01 

projects 

ERN 

actions 

3-year 

specific 

grant 

13 691 043.13 

agreements 

(SGAs)  under  Framework 

Partnership Agreement  

Operating grants for NGOs 

JA  grant 

Conference grants to the Member States 

holding the EU Presidency 

DGAs with international organisations 

Procurement  (service  contracts),  prizes 

and cross-cutting  actions 

Managed by CHAFEA 

Managed by DG SANTE 

Other actions 

Managed by CHAFEA 

Managed by DG SANTE 

Budget implemented of 2018 AWP  

5 887 958.53 

7 900 000.00 

166 000.00 

4 020 000.00 

8 924 955.22 

2 618 012.85 

6 306 942.37 

9 636 503.09 

597 659.00 

9 038 844.09 

61 322 254.98 

Managed by CHAFEA 

45 976 468.52 

Managed by DG SANTE 

15 345 786.46 

Total available budget of 2018 AWP  

62 419 043.65 

Not used 

by CHAFEA 

by DG SANTE 

 1 096 788.67 

1 096 788.67 

0.00 

50.02 

18.09 

22.33 

9.60 

12.88 

0.27 

6.56 

14.55 

4.27 

10.28 

15.71 

0.97 

14.74 

98.24 

73.66 

24.59 

1.76 

11 

 
 
  
  
 
 
Beneficiaries 

3. 
In  2018,  Chafea  and  DG  SANTE  signed  more  than  26217  grants  and  contracts  with  a  range  of 

beneficiaries and service providers: governmental organisations, academic institutions, NGOs, private 
companies, and individual experts18. Other beneficiaries included international organisations and EU 

departments. There were 423 beneficiaries in total, the two main categories being private companies 

(for procurement and other actions) and governmental organisations (for JAs and projects). 

Chart 3 shows the various groups of beneficiaries. 

Chart 3: Third health programme beneficiaries in 2018 – main categories 

Research 
institutions 
17% 

Commission 
departments 
[PERCENTAGE] 

Private 
organisations 
21% 

Governmental 
organisations 
42% 

Non 
governmental 
oganisations 
[PERCENTAGE] 

MAIN COMMUNICATION ACTIONS 

On programme implementation monitoring, Chafea contributed to the preparatory work for the MFF 

2021-2027  by  gathering  information  on  the  health  programme  (2014-2017)  results.  Following  the 

adoption  of  Chafea’s  strategy  for  the  dissemination  of  the  programme  (June  2017),  the  annual 

dissemination  plan  for  2018  focused  on  the  Commission’s  key  priorities  for  health,  namely  the 

European ERNs and crisis preparedness and response. 

For ERNs:  

17 

JA (1), PJ (9), operating grants SGA (16), ERN (23), direct grant agreement with international organisations (5), prizes (2), conferences 
(2), tenders and cross-cutting actions (181), other actions (23). 

18  These 262 grants and contracts do not include those signed with individual experts participating in scientific committees, evaluators of 

calls for proposals, etc. 

12 

 
 
 
                                                      
  production of the e-booklet ‘Rare diseases 2008-2016: EU-funded actions paving the way to 

the European Reference Networks’19;  

  production of the info sheet ‘EU health programme support to ERNs: helping people suffering 
from  rare and low-prevalence complex  diseases’20,  presented at  the  fourth conference  of  the 

ERNs, held on 21-22 November 2018 in Brussels. 

For crisis preparedness: 

  production and publication of the e-booklet ‘Health threats 2009-2018: EU-funded actions for 

better preparedness and coordination in health crisis’21; 

  production and publication of the info sheet ‘Medical countermeasures: vaccines and 

 

vaccination’22; 
conference,  ‘Best  practices  in  implementing  the  international  health  regulations’,  held  on  7-
8 June 2018 in Athens, Greece, in cooperation with the Greek Ministry of Health23. 

Chafea  participated  in  five  major  EU-wide  public  health  conferences  where  scientists  and  health 

professionals were the target audience. 

  18th 

International  Conference  on 

Integrated  Care,  23-25 May 2018,  Utrecht, 

the 

Netherlands24. Workshops and stand on the health programme. 

  21st European Health Forum Gastein, 3-5 October 201825. Stand organised. 

  11th  European  Public  Health  Conference  2018,  28 November-1 December 2018,  ‘Winds  of 
change: towards new ways of improving public health in Europe’, Ljubljana, Slovenia26. Two 

pre-conferences  were  held  that  focused  on  EU  actions  on  antimicrobial  resistance  and 

healthcare-associated  infections.  Lunch  symposium:  The  EU  health  programme  successes  - 
contributing to better health for all in the EU27. 

  49th  Union  World  Conference  on  Lung  Health,  24-27 October 201828.  Stand  exhibition  and 

‘meet  and  greet  the  health  programme  experts’  sessions  were  organised.  The  Hague,  the 

Netherlands. 

19  https://op.europa.eu/en/publication-detail/-/publication/fd1f05fc-6def-11e8-9483-01aa75ed71a1/language-

en?WT.mc_id=Selectedpublications&WT.ria_c=19980&WT.ria_f=3170&WT.ria_ev=search  

20  https://op.europa.eu/en/publication-detail/-/publication/d4deee56-e952-11e8-b690-01aa75ed71a1/language-

en?WT.mc_id=Selectedpublications&WT.ria_c=19980&WT.ria_f=3171&WT.ria_ev=search  

21  https://op.europa.eu/en/publication-detail/-/publication/13b6f22d-75e4-11e8-ac6a-01aa75ed71a1/language-

en?WT.mc_id=Selectedpublications&WT.ria_c=19980&WT.ria_f=3170&WT.ria_ev=search  

22  https://publications.europa.eu/en/publication-detail/-/publication/9807f2a3-d7ff-11e8-90c0-01aa75ed71a1/language-

en?WT.mc_id=Selectedpublications&WT.ria_c=19980&WT.ria_f=3171&WT.ria_ev=search  
23  https://eody.gov.gr/en/event/best-practices-in-implementing-the-international-health-regulations/  
24  https://integratedcarefoundation.org/events/icic18-18th-international-conference-on-integrated-care-utrecht  
25  https://www.ehfg.org/archive/2018/conference  
26  https://ephconference.eu/conference-2018-Ljubljana-184  
27  https://ephconference.eu/2018-pre-conference-programme-158  
28  https://thehague.worldlunghealth.org/  

13 

 
 
                                                      
  AIDS 2018, health programme workshops, 23-27 July 201829. EU stand and ‘meet and greet 

the health programme experts’ sessions were organised, in Amsterdam, the Netherlands. The 

e-booklet on the conference was produced and disseminated. 

29  https://www.aids2018.org/  

14